Overview of Arize Prosthetics Inc.

The Advanced Universal Prosthetic Socket is a first-of-its-kind, mass-manufactured prosthetic solution that eliminates the costly liner-based suspension systems used in traditional prosthetics. Designed for scalability and affordability, it features a tightening mechanism for effortless customized fit, waterproof and antibacterial construction, and ships mostly assembled for immediate use — no specialist required. By engineering out the complexity and cost of traditional prosthetics, Arize has built a product that can be sold at a fraction of the market price while maintaining premium performance.

Arize is tackling one of the largest unmet needs in global healthcare: prosthetic inaccessibility. Of the 60+ million amputees worldwide, over 90% cannot afford traditional prosthetics — representing a massive underserved market. Our product delivers measurable outcomes. Unlike legacy prosthetics that require clinical fittings and specialized technicians, Arize ships direct-to-consumer and through distribution partners — creating a highly scalable, low-overhead go-to-market model. The $5M raise will fund manufacturing scale, regulatory approvals, and the distribution infrastructure to reach VA networks, international NGOs, and direct consumers at volume.

Primary beneficiaries are the 60+ million amputees worldwide — particularly the 90%+ who are currently priced out of traditional prosthetics, including underserved communities in the U.S., veterans, and amputees in developing nations. From an investor perspective, this represents a largely untapped, high-volume market within the $11B+ global prosthetics industry. Secondary customers include VA networks, international NGOs, rehabilitation centers, and healthcare systems seeking cost-effective prosthetic solutions at scale.

As part of our $5M raise, Arize is actively seeking co-investors, lead investors, and strategic partners who can add value beyond capital. Key collaboration opportunities include: co-investment with impact funds, healthcare-focused VCs, and disability-focused family offices; channel partnerships with VA networks, international NGOs, and medical supply distributors to accelerate revenue growth; R&D partnerships with universities and rehabilitation centers to strengthen IP and clinical validation; and advocacy partnerships with disability organizations to build brand equity and community trust. We are open to conversations with any partner aligned with our vision of accessible prosthetics at scale.

Arize Innovations is raising a $5M seed round. Use of funds: 40% manufacturing scale-up to meet growing demand and reduce per-unit cost; 25% sales and distribution buildout including VA network onboarding and international channel partnerships; 20% regulatory compliance and clinical validation to unlock additional market channels; 15% team expansion across operations, sales, and engineering. With this capital, we project significant revenue growth within 18-24 months, positioning Arize as the leading affordable prosthetics brand. We are currently in active conversations with investors and are seeking to close the round with aligned partners who share our impact-driven vision.